Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) [Phase 1]
Dizal Pharmaceuticals is conducting a Phase 1 mass-balance pharmacokinetic study of DZD8586 in healthy male participants (TAI-SHAN15); the t…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders [NA]
This update reports the completed status of a trial assessing bone marrow and kidney transplant for patients with chronic kidney disease and…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: PIC1 Injection Therapy for Relapsed/Refractory B-NHL [Phase 1]
Phase 1 clinical trial of PIC1 Injection Therapy for relapsed/refractory B-cell non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
A clinical trial update notes a study evaluating chemotherapy-induced cognitive disorders in patients treated for hematological malignancies…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas [Phase 1, Phase 2]
Clinical trial update for SB-4826 in adults with locally advanced or metastatic solid tumors or non-Hodgkin lymphoma, currently recruiting i…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies [Phase 2]
This Phase 2 trial evaluates mosunetuzumab monotherapy for select B-cell malignancies, including Non-Hodgkin lymphoma, with the study curren…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy [Phase 3]
A Phase 3 trial compares Ronde-cel CD19 CAR T-cell therapy against investigator's choice CD19 CAR T-cell therapy in adults with large B-cell…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) [Phase 1, Phase 2]
Genmab's PRO1160 (GEN1160) Phase 1/2 trial in relapsed or refractory non-Hodgkin lymphoma has been terminated; the study also included renal…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma [Phase 2]
A Phase 2 trial of response-adapted therapy with copanlisib plus rituximab in previously untreated follicular lymphoma; results were posted …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CHO-H01 as a single agent or in combination with lenalidomide for refractory or relapsed Non-Hodgkin l…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome [Phase 2]
A Phase 2 clinical trial update evaluating the combination of zanubrutinib and lisocabtagene maraleucel for Richter's syndrome, with patient…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of Oral LOXO-338 in Patients With Advanced Blood Cancers [Phase 1]
Phase 1 study of oral LOXO-338 in advanced blood cancers is ongoing, with status listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes (GRALE) for EBV-positive lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib [Phase 4]
This document describes a Phase 4 master protocol studying the long-term safety of Pirtobrutinib (LY3527727). The study is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma [Phase 4]
This clinical trial update reports a Phase 4 study of pirtobrutinib (LY3527727) in previously treated chronic lymphocytic leukemia/small lym…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Roche is conducting a Phase 1/2 trial to evaluate Englumafusp Alfa in combination with Obinutuzumab and in combination with Glofitamab after…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Impact of Respiratory Training in Lymphoma Survivors [NA]
A terminated clinical trial evaluating respiratory training in lymphoma survivors has posted results as of 2026-02-27. The study was sponsor…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study
This clinical trial update describes the Mayo Clinic LEO Study evaluating prognosis and survivorship in recently diagnosed patients with Non…
-
CLINICAL_TRIALS other · 2026-02-27Clinical Trial Update: AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma [Phase 1]
This is a Phase 1 clinical trial update on anti-CD19 CAR-T cells for relapsed or refractory non-Hodgkin lymphoma, currently active but not r…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pedia…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies [Phase 1, Phase 2]
A first-in-human study evaluating HLA partially to fully matched allogeneic, cryopreserved deceased donor bone marrow transplantation for va…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma [Phase 1]
Phase 1 trial update of ViPOR-P (venetoclax, ibrutinib, prednisone, obinutuzumab, lenalidomide) in combination with polatuzumab for relapsed…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …